Adaptive Biotechnologies
ADPT
$2.60
Share price
-0.38%
Change (1 day)
-63.59%
Change (1 year)
Categories
Adaptive Biotechnologies (ADPT) - Cash on Hand
Cash on Hand as of December 2023 : $0.34 B
According to Adaptive Biotechnologies
's latest financial reports the company has $0.34 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Adaptive Biotechnologies - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.34 B | -30.47% |
| 2022-12-31 | $0.49 B | 41.11% |
| 2021-12-31 | $0.35 B | -48.7% |
| 2020-12-31 | $0.68 B | 19.31% |
| 2019-12-31 | $0.57 B | 249.58% |
| 2018-12-31 | $0.16 B | -14.12% |
| 2017-12-31 | $0.19 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 HCA Healthcare HCA | $0.93 B | 169.92% | 🇺🇸 USA |
 Premier PINC | $0.37 B | 7.13% | 🇺🇸 USA |
 Community Health Systems
CYH | $38 M | -89.03% | 🇺🇸 USA |
 Select Medical Holdings SEM | $0.14 B | -58.73% | 🇺🇸 USA |